The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Molecular Control of Lymphatic Metastasis
Abstract
The metastatic spread of tumor cells is the most lethal aspect of cancer and often occurs via the lymphatic vasculature. Both experimental tumor models and human clinicopathologic data indicate that growth of lymphatic vessels (lymphangiogenesis) near solid tumors is often associated with lymph node metastasis. Changes in the adhesive properties of lymphatic endothelium near tumors may also facilitate metastatic spread via the lymphatics. Lymphangiogenic growth factors have been identified that promote formation of tumor lymphatics and metastatic spread of tumor cells to lymph nodes. These include the secreted glycoproteins vascular endothelial growth factor‐C (VEGF‐C) and VEGF‐D, which act via their cognate receptor tyrosine kinase VEGF receptor‐3 (VEGFR‐3) located on lymphatic endothelial cells. Other signaling molecules that have been reported to promote lymphangiogenesis and/or lymphatic metastasis in cancer include VEGF‐A, platelet‐derived growth factor‐BB, and hepatocyte growth factor. However, the quantitative contribution of these proteins to tumor lymphangiogenesis and lymphatic metastasis in different tumor types requires further investigation. In addition, chemokines are thought to play a role in attracting tumor cells and lymphatic vessels to each other. Moreover, it has recently been shown that lymphangiogenic growth factors secreted from a primary tumor can induce lymphangiogenesis in nearby lymph nodes, even before arrival of tumor cells, which may facilitate further metastasis. This article provides an overview of the molecular mechanisms that control lymphatic metastasis and discusses potential therapeutic approaches for inhibiting this process in human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K., Claffey, K., & Detmar, M. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S.-I., Kubo, H., & Achen, M. G. (2001) · Nature Medicine · doi:10.1038/84635 · Cited by 1,246
Self-citationAchen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., & Stacker, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.548 · Cited by 1,205
Self-citationFisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B., Foster, R., Gardner, B., Lerner, H., Margolese, R., et al. (1983) · Cancer · doi:10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3 · Cited by 1,034
Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, D., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00217-4 · Cited by 1,018
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
Mandriota, S. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.672 · Cited by 978
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H.-P., & Ferrara, N. (2007) · Nature Biotechnology · doi:10.1038/nbt1323 · Cited by 849
Chemokines: immunology's high impact factors
Mackay, C. R. (2001) · Nature Immunology · doi:10.1038/84298 · Cited by 845
Makinen, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4762 · Cited by 845
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Self-citationProteolytic processing regulates receptor specificity and activity of VEGF-C
Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., & Alitalo, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3898 · Cited by 773
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
Hirakawa, S., Kodama, S., Kunstfeld, R., Kajiya, K., Brown, L. F., & Detmar, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041896 · Cited by 719
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1223 · Cited by 663
Self-citationKärpänen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Ylä‐Herttuala, S., Jäättelä, M., & Alitalo, K. K. (2001) · PubMed · Cited by 651
Ikeda, E., Achen, M. G., Breier, G., & Risau, W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19761 · Cited by 594
Self-citationVascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson-Welsh, L., & Alitalo, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 565
VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., & Alitalo, K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65392-8 · Cited by 541
VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Hirakawa, S., Brown, L. F., Kodama, S., Paavonen, K., Alitalo, K., & Detmar, M. (2007) · Blood · doi:10.1182/blood-2006-05-021758 · Cited by 533
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis
Cao, R., Björndahl, M. A., Religa, P., Clasper, S., Garvin, S., Galter, D., Meister, B., Ikomi, F., Tritsaris, K., Dissing, S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.034 · Cited by 527
He, Y., Kozaki, K.-I., Karpanen, T., Koshikawa, K., Yla-Herttuala, S., Takahashi, T., & Alitalo, K. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.819 · Cited by 521
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Verheul, H. M. W., & Pinedo, H. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2152 · Cited by 503
Plate, K. H., Breier, G., Millauer, B., Ullrich, A., & Risau, W. (1993) · PubMed · Cited by 498
Oh, S.-J., Jeltsch, M. M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitalo, K., & Wilting, J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8639 · Cited by 498
Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., Ellwanger, U., Garbe, C., Mihm, M. C., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64328-3 · Cited by 484
Rissanen, T. T., Markkanen, J. E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M. I., Kholová, I., Kauppinen, R. A., Achen, M. G., Stacker, S. A., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000073584.46059.e3 · Cited by 442
Self-citationLymphangiogenesis and tumor metastasis: myth or reality?
Pepper, M. S. (2001) · PubMed · Cited by 418
Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer.
Beasley, N. J. P., Prevo, R., Banerji, S., Leek, R., Moore, J. C., Trappen, P. O. V., Cox, G. J., Harris, A. L., & Jackson, D. G. (2002) · PubMed · Cited by 413
Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
Roskoski, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.156 · Cited by 412
He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Jooss, K., Takahashi, T., & Alitalo, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4576 · Cited by 410
Bunone, G., Vigneri, P., Mariani, L., Butó, S., Collini, P., Pilotti, S., Pierotti, M. A., & Bongarzone, I. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65515-0 · Cited by 404
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391
Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., & Detmar, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61765-8 · Cited by 388
Harrell, M. I., Iritani, B. M., & Ruddell, A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060761 · Cited by 388
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
Wiley, H. E., Gonzalez, E. B., Maki, W., Wu, M.-T., & Hwang, S. T. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1638 · Cited by 377
Hoshida, T., Isaka, N., Hagendoorn, J., di Tomaso, E., Chen, Y.-L., Pytowski, B., Fukumura, D., Padera, T. P., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1392 · Cited by 361
Focus on lymphangiogenesis in tumor metastasis
Achen, M. G., McColl, B. K., & Stacker, S. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.017 · Cited by 351
Self-citationWitzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J.-S., & Isner, J. M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65582-4 · Cited by 346
Stacker, S. A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R. J., Moritz, R., Karpanen, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32127 · Cited by 327
Self-citationTumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes
Dadras, S. S., Lange-Asschenfeldt, B., Velasco, P., Nguyen, L., Vora, A., Muzikansky, A., Jahnke, K., Hauschild, A., Hirakawa, S., Mihm, M. C., et al. (2005) · Modern Pathology · doi:10.1038/modpathol.3800410 · Cited by 326
Hepatocyte growth factor promotes lymphatic vessel formation and function
Kajiya, K., Hirakawa, S., Ma, B., Drinnenberg, I., & Detmar, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600763 · Cited by 322
Roberts, N., Kloos, B., Cassella, M., Podgrabinska, S., Persaud, K., Wu, Y., Pytowski, B., & Skobe, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1843 · Cited by 315
Qian, C.-N., Berghuis, B., Tsarfaty, G., Bruch, M., Kort, E. J., Ditlev, J., Tsarfaty, I., Hudson, E., Jackson, D. G., Petillo, D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2977 · Cited by 312
Yonemura, Y., Endo, Y., Fujita, H., Fushida, S., Ninomiya, I., Bandou, E., Taniguchi, K., Miwa, K., Ohoyama, S., Sugiyama, K., et al. (1999) · PubMed · Cited by 311
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.
Mashino, K., Sadanaga, N., Yamaguchi, H., Tanaka, F., Ohta, M., Shibuta, K., Inoue, H., & Mori, M. (2002) · PubMed · Cited by 298
The role of tumor lymphangiogenesis in metastatic spread
STACKER, S. A., BALDWIN, M. E., & ACHEN, M. G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0945rev · Cited by 296
Self-citationRole of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis
Thurston, G. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0749-6 · Cited by 294
Vascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., & Achen, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2441-2449.2005 · Cited by 289
Self-citationDixelius, J., Mäkinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., & Claesson-Welsh, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304499200 · Cited by 284
Tsurusaki, T., Kanda, S., Sakai, H., Kanetake, H., Saito, Y., Alitalo, K., & Koji, T. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690356 · Cited by 280
Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes
Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1757 · Cited by 272
Lin, J., Lalani, A. S., Harding, T. C., Gonzalez, M., Wu, W.-W., Luan, B., Tu, G. H., Koprivnikar, K., VanRoey, M. J., He, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0408 · Cited by 269
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch‐Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15418 · Cited by 268
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
Björndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., & Cao, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507865102 · Cited by 249
Pytowski, B., Goldman, J., Persaud, K., Wu, Y., Witte, L., Hicklin, D. J., Skobe, M., Boardman, K. C., & Swartz, M. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji003 · Cited by 248
CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer
Cabioglu, N., Yazici, M. S., Arun, B., Broglio, K. R., Hortobagyi, G. N., Price, J. E., & Sahin, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0014 · Cited by 246
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch-Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215418 · Cited by 244
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
Kawada, K., Hosogi, H., Sonoshita, M., Sakashita, H., Manabe, T., Shimahara, Y., Sakai, Y., Takabayashi, A., Oshima, M., & Taketo, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210267 · Cited by 243
Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
Laakkonen, P., Waltari, M., Holopainen, T., Takahashi, T., Pytowski, B., Steiner, P., Hicklin, D., Persaud, K., Tonra, J. R., Witte, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3567 · Cited by 241
Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
Tammela, T., Saaristo, A., Lohela, M., Morisada, T., Tornberg, J., Norrmén, C., Oike, Y., Pajusola, K., Thurston, G., Suda, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3327 · Cited by 236
Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M., Shimizu, K., Awane, M., Sakai, Y., Takabayashi, A., Alitalo, K., et al. (2000) · Blood · doi:10.1182/blood.v96.2.546 · Cited by 235
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Morisada, T., Oike, Y., Yamada, Y., Urano, T., Akao, M., Kubota, Y., Maekawa, H., Kimura, Y., Ohmura, M., Miyamoto, T., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3382 · Cited by 235
Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
Akagi, K., Ikeda, Y., Miyazaki, M., Abe, T., Kinoshita, J., Maehara, Y., & Sugimachi, K. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1396 · Cited by 230
Jüttner, S., Wiβmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P. M., Kemmner, W., & Höcker, M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.3467 · Cited by 228
The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis
Siegfried, G., Basak, A., Cromlish, J. A., Benjannet, S., Marcinkiewicz, J., Chrétien, M., Seidah, N. G., & Khatib, A.-M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17220 · Cited by 226
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
Salvucci, O., Bouchard, A., Baccarelli, A., Deschenes, J., Sauter, G., Simon, R., Bianchi, R., & Basik, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9121-8 · Cited by 221
Leak, L. V. (1970) · Microvascular Research · doi:10.1016/0026-2862(70)90031-2 · Cited by 212
White, J., Hewett, P. W., Kosuge, D. D., McCulloch, T., Enholm, B., Carmichael, J., & Murray, J. C. (2002) · PubMed · Cited by 212
Tumor and lymph node lymphangiogenesis—impact on cancer metastasis
Tobler, N. E., & Detmar, M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105653 · Cited by 208
Van der Auwera, I., Cao, Y., Tille, J. C., Pepper, M. S., Jackson, D. G., Fox, S. B., Harris, A. L., Dirix, L. Y., & Vermeulen, P. B. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603445 · Cited by 202
Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
McColl, B. K., Baldwin, M. E., Roufail, S., Freeman, C., Moritz, R. L., Simpson, R. J., Alitalo, K., Stacker, S. A., & Achen, M. G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030361 · Cited by 197
Self-citationRutanen, J., Rissanen, T. T., Markkanen, J. E., Gruchala, M., Silvennoinen, P., Kivelä, A., Hedman, A., Hedman, M., Heikura, T., Ordén, M.-R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000115519.03688.a2 · Cited by 190
Self-citationHepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action
Cao, R., Björndahl, M. A., Gallego, M. I., Chen, S., Religa, P., Hansen, A. J., & Cao, Y. (2006) · Blood · doi:10.1182/blood-2005-06-2538 · Cited by 189
Krishnan, J., Kirkin, V., Steffen, A., Hegen, M., Weih, D., Tomarev, S. I., Wilting, J., & Sleeman, J. P. (2003) · PubMed · Cited by 187
Lymphatic function, lymphangiogenesis, and cancer metastasis
Swartz, M. A., & Skobe, M. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1160 · Cited by 183
Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7
Günther, K., Leier, J., Henning, G., Dimmler, A. W., Weißbach, R., Hohenberger, W., & Förster, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21123 · Cited by 182
Renyi-Vamos, F., Tovari, J., Fillinger, J., Timar, J., Paku, S., Kenessey, I., Ostoros, G., Agocs, L., Soltesz, I., & Dome, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1077 · Cited by 181
Role of lymphangiogenic factors in tumor metastasis
He, Y., Karpanen, T., & Alitalo, K. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.07.003 · Cited by 179
Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis
Björndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., Wu, L., & Cao, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2345 · Cited by 178
SAARISTO, A., VEIKKOLA, T., ENHOLM, B., HYTÖNEN, M., AROLA, J., PAJUSOLA, K., TURUNEN, P., JELTSCH, M., KARKKAINEN, M. J., KERJASCHKI, D., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-1042com · Cited by 177
Expression of vascular endothelial growth factor and its receptors in rat neural stem cells
Maurer, M. H., Tripps, W. K. C., Feldmann, R., & Kuschinsky, W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00407-5 · Cited by 170
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4
Schimanski, C. C., Bahre, R., Gockel, I., Müller, A., Frerichs, K., Hörner, V, Teufel, A., Simiantonaki, N., Biesterfeld, S., Wehler, T., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603251 · Cited by 168
Targeting lymphangiogenesis to prevent tumour metastasis
Achen, M. G., Mann, G. B., & Stacker, S. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603120 · Cited by 166
Self-citationShields, J. D., Emmett, M. S., Dunn, D. B. A., Joory, K. D., Sage, L. M., Rigby, H., Mortimer, P. S., Orlando, A., Levick, J. R., & Bates, D. O. (2007) · Oncogene · doi:10.1038/sj.onc.1210114 · Cited by 165
Kajita, T., Ohta, Y., Kimura, K., Tamura, M., Tanaka, Y., Tsunezuka, Y., Oda, M., Sasaki, T., & Watanabe, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1882 · Cited by 164
Wong, S. Y., Haack, H., Crowley, D. G., Barry, M., Bronson, R. T., & Hynes, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0901 · Cited by 154
Yokoyama, Y., Jones, D. S., Licence, D., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., UMEMOTO, M., Sakamoto, T., Sato, S., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600701 · Cited by 152
Vallet, S., Raje, N. S., Ishitsuka, K., Hideshima, T., Podar, K., Chhetri, S., Pozzi, S., Breitkreutz, I., Kiziltepe, T., Yasui, H., et al. (2007) · Blood · doi:10.1182/blood-2007-05-093294 · Cited by 152
Lymphangiogenic Growth Factor Responsiveness Is Modulated by Postnatal Lymphatic Vessel Maturation
Kärpänen, T., Wirzenius, M., Mäkinen, T., Veikkola, T., Haisma, H. J., Achen, M. G., Stacker, S. A., Pytowski, B., Ylä‐Herttuala, S., & Alitalo, K. K. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051200 · Cited by 142
Self-citationYokoyama, Y., Jones, D. S., Licence, D. R., Yanaihara, A., Hastings, J. M., Holland, C. M., Emoto, M., Sakamoto, A., Sakamoto, T., Maruyama, H., et al. (2003) · PubMed · Cited by 139
Manley, P. W., Bold, G., Brüggen, J., Fendrich, G., Furet, P., Mestan, J., Schnell, C., Stolz, B., Meyer, T., Meyhack, B., et al. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.010 · Cited by 136
Distinct Roles of Vascular Endothelial Growth Factor-D in Lymphangiogenesis and Metastasis
Kopfstein, L., Veikkola, T., Djonov, V., Baeriswyl, V., Schomber, T., Strittmatter, K., Stacker, S. A., Achen, M. G., Alitalo, K. K., & Christofori, G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060835 · Cited by 136
Self-citationSorafenib and Sunitinib in the Treatment of Advanced Non-Small Cell Lung Cancer
Gridelli, C., Maione, P., Gaizo, F. D., Colantuoni, G., Guerriero, C., Ferrara, C., Nicolella, D., Comunale, D., Vita, A. D., & Rossi, A. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-191 · Cited by 128
McColl, B., Paavonen, K., Karnezis, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7060com · Cited by 121
Byzova, T. V., Goldman, C. K., Jankau, J., Chen, J., Cabrera, G., Achen, M. G., Stacker, S. A., Carnevale, K. A., Siemionow, M., Deitcher, S. R., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4434 · Cited by 113
Self-citationAchen, M. G., Roufail, S., Domagala, T., Catimel, B., Nice, E. C., Geleick, D., Murphy, R., Scott, A. M., Caesar, C., Mäkinen, T., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01257.x · Cited by 112
Self-citationVascular Endothelial Growth Factor Receptor-3
Taipale, J., Mäkinen, T., Arighi, E., Kukk, E., Karkkainen, M. J., & Alitalo, K. K. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59953-8_5 · Cited by 107
Zeng, Y., Opeskin, K., Baldwin, M. E., Horvath, L. G., Achen, M. G., Stacker, S. A., Sutherland, R. L., & Williams, E. D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0434 · Cited by 103
Self-citationTumor-induced lymphangiogenesis: A target for cancer therapy?
Thiele, W., & Sleeman, J. P. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.01.007 · Cited by 100
Whitehurst, B. D., Flister, M. J., Bagaitkar, J., Volk, L. D., Bivens, C., Pickett, B., Castro‐Rivera, E., Brekken, R. A., Gerard, R. D., & Ran, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22937 · Cited by 97
Tang, Y., Zhang, D., Fallavollita, L., et al. (2003) · PubMed · Cited by 84
Uchida, D., Begum, N.-M., Tomizuka, Y., Bando, T., Almofti, A., Yoshida, H., & Sato, M. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700190 · Cited by 83
VEGF-D is an X-linked/AP-1 Regulated Putative Onco-angiogen in Human Glioblastoma Multiforme
Debinski, W., Slagle‐Webb, B., Achen, M. G., Stacker, S. A., Tulchinsky, E. M., Gillespie, G. Y., & Gibo, D. M. (2001) · Molecular Medicine · doi:10.1007/bf03401866 · Cited by 78
Self-citationUeda, M., Terai, Y., Yamashita, Y., Kumagai, K., Ueki, K., Yamaguchi, H., Akise, D., Hung, Y., & Ueki, M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10193 · Cited by 78
Gannon, G., Mandriota, S. J., Cui, L., Baetens, D., Pepper, M. S., & Christofori, G. (2002) · PubMed · Cited by 78
Baldwin, M. E., Roufail, S., Halford, M. M., Alitalo, K. K., Stacker, S. A., & Achen, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106188200 · Cited by 75
Self-citationAchen, M. G., Williams, R. A., Baldwin, M. E., Lai, P., Roufail, S., Alitalo, K. K., & Stacker, S. A. (2002) · Growth Factors · doi:10.1080/08977190290031969 · Cited by 61
Self-citationLocation, movement and survival: the role of chemokines in haematopoiesis and malignancy
Laurence, A. D. J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05841.x · Cited by 57
Mita, K., Nakahara, M., & Usui, T. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00200.x · Cited by 38
Molecular Targeting of Lymphatics for Therapy
Stacker, S. A., Hughes, R., & Achen, M. G. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453513 · Cited by 36
Self-citation
Cited by
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 373
The impact of VEGF on cancer metastasis and systemic disease
Yang, Y., & Cao, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.011 · Cited by 286
Karnezis, T., Shayan, R., Caesar, C., Roufail, S., Harris, N. C., Ardipradja, K., Zhang, Y. F., Williams, S. P., Farnsworth, R. H., Chai, M. G., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.026 · Cited by 281
Self-citation
Metadata
- Authors
- Achen, M. G., & Stacker, S. A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2008-05
- Volume
- 1131
- Issue
- 1
- Pages
- 225-234
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1969529130
- Cited by
- 260
- References
- 123
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.